China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

Beijing’s action against clothing maker PVH and biotech company Illumina underlines risk created by trade tensions ...

The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...

The "Genomic Data Analysis and Interpretation Market Opportunities and Strategies to 2033" report has been added to ...

Market OverviewThe Global Carrier Screening Market is a genetic testing process that determines whether an individual carries ...

Precision medicine is an innovative approach in healthcare that takes into account individual differences in genes, ...

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

Asian equities were mostly lower overnight as Pakistan and Thailand outperformed and Hong Kong and Indonesia underperformed.

Star portfolio manager Cathie Wood’s Ark Investment Management filed its 13F holdings report for the fourth quarter on Feb. 4 ...

Pacific Biosciences of California, Inc. ( NASDAQ: PACB) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET Todd Friedman - Senior Director, Finance and Investor Relations Christian Henry - ...

We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...